Abstract
Raman spectroscopy is a promising technique for the identification and analysis of molecules in a sample without any labeling or modification. Since Raman scattering spectra provide information about intracellular molecular distributions, metabolism and chemical reactions, Raman microscopy has been widely utilized for bio-imaging and biofunctional analysis. By using metallic nanostructures, Raman scattering from molecules at the vicinity of a metal surface is significantly enhanced, which is called surface-enhanced Raman scattering (SERS). Due to localized field enhancement, the highly sensitive detection of molecules can be achieved and many attempts to apply it for biological and biomedical research have been made. In this article, we review the applications of metallic nanoparticles as SERS agents for molecular analysis and imaging of biological cells and tissues.
Keywords: Surface enhanced raman scattering, metallic nanoparticles, raman microscopy, biomolecular imaging, plasmonics, biophysics and biomedical science
Current Pharmaceutical Biotechnology
Title:Metallic Nanoparticles as SERS Agents for Biomolecular Imaging
Volume: 14 Issue: 2
Author(s): Jun Ando and Katsumasa Fujita
Affiliation:
Keywords: Surface enhanced raman scattering, metallic nanoparticles, raman microscopy, biomolecular imaging, plasmonics, biophysics and biomedical science
Abstract: Raman spectroscopy is a promising technique for the identification and analysis of molecules in a sample without any labeling or modification. Since Raman scattering spectra provide information about intracellular molecular distributions, metabolism and chemical reactions, Raman microscopy has been widely utilized for bio-imaging and biofunctional analysis. By using metallic nanostructures, Raman scattering from molecules at the vicinity of a metal surface is significantly enhanced, which is called surface-enhanced Raman scattering (SERS). Due to localized field enhancement, the highly sensitive detection of molecules can be achieved and many attempts to apply it for biological and biomedical research have been made. In this article, we review the applications of metallic nanoparticles as SERS agents for molecular analysis and imaging of biological cells and tissues.
Export Options
About this article
Cite this article as:
Ando Jun and Fujita Katsumasa, Metallic Nanoparticles as SERS Agents for Biomolecular Imaging, Current Pharmaceutical Biotechnology 2013; 14 (2) . https://dx.doi.org/10.2174/1389201011314020003
DOI https://dx.doi.org/10.2174/1389201011314020003 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets Galectins: Major Signaling Modulators Inside and Outside the Cell
Current Molecular Medicine The Need for Calcium Channels in Cell Proliferation
Recent Patents on Anti-Cancer Drug Discovery Application of the Shortest Path Algorithm for the Discovery of Breast Cancer-Related Genes
Current Bioinformatics Quantitative Structure-Wavelength Relationship Modeling of Porphin -Derivative Photosensitizers
Combinatorial Chemistry & High Throughput Screening Zebrafish: A Complete Animal Model for In Vivo Drug Discovery and Development
Current Drug Metabolism The Molecular Basis of Notch Signaling Regulation: A Complex Simplicity
Current Molecular Medicine Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Current Drug Targets Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain
Current Drug Targets Expression and Functions of Vasoactive Substances Regulated by Hypoxia-Inducible Factor-1 in Chronic Hypoxemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin
Anti-Cancer Agents in Medicinal Chemistry Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
Current Pharmaceutical Design Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Mini-Reviews in Medicinal Chemistry HSP60 as a Drug Target
Current Pharmaceutical Design Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Epigenetic Regulators Governing Cancer Stem Cells and Epithelial- Mesenchymal Transition in Oral Squamous Cell Carcinoma
Current Stem Cell Research & Therapy Molecular Chaperone ORP150 in ER Stress–related Diseases
Current Pharmaceutical Design